Department of Biochemistry and Biotechnology, University of Life Sciences, Poznań, Poland.
Adv Exp Med Biol. 2010;660:113-27. doi: 10.1007/978-1-60761-350-3_11.
The thioester homocysteine (Hcy)-thiolactone, product of an error-editing reaction in protein biosynthesis, forms when Hcy is mistakenly selected by methionyl-tRNA synthetase. Accumulating evidence suggests that Hcy-thiolactone plays an important role in atherothrombosis. The thioester chemistry of Hcy-thiolactone underlies its ability to form isopeptide bonds with protein lysine residues, which impairs or alters protein function and has pathophysiological consequences including activation of an autoimmune response and enhanced thrombosis. Mammalian organisms, including human, have evolved the ability to eliminate Hcy-thiolactone. One such mechanism involves paraoxonase 1 (PON1), which has the ability to hydrolyze Hcy-thiolactone. This article outlines Hcy-thiolactone pathobiology and reviews evidence documenting the role of PON1 in minimizing Hcy-thiolactone and N-Hcy-protein accumulation.
硫酯同型半胱氨酸(Hcy)-硫内酯是蛋白质生物合成中错误编辑反应的产物,当 Hcy 被蛋氨酰-tRNA 合成酶错误选择时形成。越来越多的证据表明 Hcy-硫内酯在动脉血栓形成中起着重要作用。Hcy-硫内酯的硫酯化学性质使其能够与蛋白质赖氨酸残基形成异肽键,这会损害或改变蛋白质功能,并产生包括自身免疫反应激活和增强血栓形成在内的病理生理后果。包括人类在内的哺乳动物已经进化出消除 Hcy-硫内酯的能力。一种这样的机制涉及对氧磷酶 1(PON1),它具有水解 Hcy-硫内酯的能力。本文概述了 Hcy-硫内酯的病理生物学,并回顾了证明 PON1 在最小化 Hcy-硫内酯和 N-Hcy-蛋白质积累中的作用的证据。